Prostacyclin-analog therapy in sickle cell pulmonary hypertension

Prostacyclin-analog therapy in sickle cell pulmonary hypertension

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Nargues A. Weir, Rehan Saiyed, Shoaib Alam, Anna Conrey, Himanshu D. Desai, M. Patricia George, Jennifer H. Keeley, Elizabeth S. Klings, Alem Mehari, James G. Taylor, Caterina P. Minniti, Gregory J. Kato
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Ferrata Storti Foundation 2017-05-01
Sraith:	Haematologica
Rochtain ar líne:	https://haematologica.org/article/view/8077

Míreanna comhchosúla

Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series
de réir: Nargues A. Weir, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease
de réir: Kim-Lien Nguyen, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.
de réir: Opeyemi Abayomi Obilade, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
de réir: Mizuki Momoi, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis
de réir: Pengwei Wang, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
de réir: Agnieszka Blitek, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog
de réir: Neda Kortam, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Prostacyclin Regulation of Allergic Inflammation
de réir: Kunj Patel, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Effects Of Prostacyclın In Osteoclastıc Actıvatıon
de réir: Yalçın Işımer, et al.
Foilsithe / Cruthaithe: (1990-11-01)

RV dysfunction by MRI is associated with elevated transpulmonary gradient and poor prognosis in patients with sickle cell associated pulmonary hypertension
de réir: Nguyen Kim-Lien L, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
de réir: Farber Harrison W, et al.
Foilsithe / Cruthaithe: (2001-07-01)

The use of selexipag, a prostacyclin receptor analog, for treatment of severe pulmonary artery hypertension during pregnancy, a case report
de réir: Akram Khan, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Severe pulmonary hypertension–interstitial lung disease presenting as right ventricular failure: stabilisation with intravenous prostacyclin and maintenance with inhaled prostacyclin
de réir: Raj Parikh, et al.
Foilsithe / Cruthaithe: (2024-01-01)

15AU81, A Prostacyclin Analog, Enhances Donor-Specific Hepatocytes to Prolong the Survival of Rat Heart but Not Small Bowel Allografts
de réir: Michael J. Boyle M.D., et al.
Foilsithe / Cruthaithe: (1999-09-01)

Divergent roles of prostacyclin and PGE2 in human tendinopathy.
de réir: Bergqvist, F, et al.
Foilsithe / Cruthaithe: (2019)

Direct prostacyclin transition in pediatric patients with pulmonary hypertension
de réir: Kelly Merrill, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Divergent roles of prostacyclin and PGE2 in human tendinopathy
de réir: Filip Bergqvist, et al.
Foilsithe / Cruthaithe: (2019-03-01)

COVID19 vaccination in adults with sickle cell disease is not associated with increases in rates of pain crisis
de réir: Elana Friedman, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Common Complications of Sickle Cell Disease: A Simulation-Based Curriculum
de réir: Cassondra Cramer-Bour, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Diverse effects of prostacyclin on angiogenesis-related processes in the porcine endometrium
de réir: Magdalena Szymanska, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
de réir: Schrör Karsten, et al.
Foilsithe / Cruthaithe: (2007-01-01)

Expression changes of prostacyclin and thromboxane in blood of rats with tail vibration
de réir: Ziyu CHEN, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
de réir: Tasha R. Womack, et al.
Foilsithe / Cruthaithe: (2022-02-01)

Clinical and genetic associations with prostacyclin response in pulmonary arterial hypertension
de réir: Stephen J. Halliday, et al.
Foilsithe / Cruthaithe: (2018-09-01)

The role of inhaled prostacyclin in treating acute respiratory distress syndrome
de réir: Randi J. Searcy, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension
de réir: Irene M. Lang, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production[S]
de réir: Monika Riederer, et al.
Foilsithe / Cruthaithe: (2010-10-01)

Variants in Human Prostacyclin Receptor Gene in Patients with Migraine Headache
de réir: Fariborz Khorvash, et al.
Foilsithe / Cruthaithe: (2018-08-01)

Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells.
de réir: A A Spector, et al.
Foilsithe / Cruthaithe: (1983-12-01)

Predictors of osteoclast activity in patients with sickle cell disease
de réir: Mehdi Nouraie, et al.
Foilsithe / Cruthaithe: (2011-08-01)

Acutely Sodded Expanded Polytetrafluoroethylene Grafts Produce Only Prostacyclin: A Qualitative Difference from Saphenous Veins
de réir: Sudhen B. Desai, et al.
Foilsithe / Cruthaithe: (2000-11-01)

Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.
de réir: Deepika S Darbari, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Achieving Symptom Control in Patients with Moderate Asthma
de réir: Nargues A. Weir, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Achieving Symptom Control in Patients with Moderate Asthma
de réir: Nargues A. Weir, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Quantitative studies on the effect of prostacyclin on freshly isolated rat osteoclasts in culture.
de réir: Adebanjo, O, et al.
Foilsithe / Cruthaithe: (1994)

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
de réir: Clarke, R, et al.
Foilsithe / Cruthaithe: (1991)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
de réir: Donna Steinbacher, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Transition from parenteral prostacyclins to selexipag: safety and feasibility in selected patients
de réir: Nael Aldweib, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Use of Aerosolized Prostacyclins in Critically Ill Patients and Association With Clinical Outcomes
de réir: S. Talal Hussain, MD, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
de réir: Athénaïs Boucly, et al.
Foilsithe / Cruthaithe: (2022-01-01)